We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
84 hedge funds and large institutions have $83.5M invested in Zevra Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
218% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 11
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
60% more capital invested
Capital invested by funds: $52.1M → $83.5M (+$31.5M)
9% more funds holding
Funds holding: 77 → 84 (+7)
0.39% less ownership
Funds ownership: 31.82% → 31.43% (-0.39%)
44% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $2.11M
Holders
84
Holders Change
+7
Holders Change %
+9.09%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
35
Reduced
11
Closed
7
Calls
$1.19M
Puts
$2.11M
Net Calls
-$923K
Net Calls Change
-$359K
Top Buyers
| 1 |
6CM
683 Capital Management
New York
|
+$2.53M |
| 2 |
AC
Armistice Capital
New York
|
+$1.25M |
| 3 |
BlackRock
New York
|
+$1.22M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$782K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$679K |
